8-K current report · filed Mar 3, 2026

SELECT MEDICAL HOLDINGS CORP (SEM) 8-K Current Report: March 3, 2026

Item 1.01Item 7.01SEM overview

Short answer

SELECT MEDICAL HOLDINGS CORP (SEM) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure). Merger Consideration: $16.50/share cash; SEM shareholders receive fixed takeout price, shares to be delisted from NYSE upon close.

SELECT MEDICAL HOLDINGS CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Merger Consideration: $16.50/share cash; SEM shareholders receive fixed takeout price, shares to be delisted from NYSE upon close
  • Buyer is Stallion Intermediate Corp, financed by private equity firm WCAS XIV, L.P. (Welsh, Carson, Anderson & Stowe) via equity + debt commitment letters
  • Deal requires majority vote of unaffiliated shareholders (excluding Rollover Holders/Parent affiliates): double approval threshold raises execution risk slightly
  • Termination fees asymmetric: SEM pays $66.5M if it walks for superior proposal; Parent pays $133.0M if it fails to close, ~2x reverse breakup fee signals buyer commitment
  • Outside date December 1, 2026 (extendable to March 1, 2027); conditions include HSR antitrust clearance and healthcare regulatory approvals

Item 7.01 · Regulation FD Disclosure

  • SEM undergoing proposed go-private acquisition: company filing Schedule 14A proxy and Schedule 13E-3, signaling a take-private or buyout structure
  • Stockholder vote required to approve merger: failure to obtain approval is an explicit deal-closing risk
  • Termination fee payable by SEM under certain conditions if merger is abandoned: potential cash cost to shareholders if deal falls through
  • "Rollover Holders" identified as solicitation participants: insiders rolling equity into new entity, interests may diverge from public shareholders
  • Stock price decline risk explicitly flagged if merger is not consummated: downside scenario for investors holding SEM anticipating deal close

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other SELECT MEDICAL HOLDINGS CORP 8-K filings

Get the next SEM 8-K as it lands

Follow SEM for push alerts, or ask the research agent what this filing means.